Further studies are needed to investigate the role of APOE4 in pulmonary ACE2 levels and their possible association with worse COVID-19 outcomes after controlling for confounding factors, such as known comorbidities and other ill-related factors. This evidence concerns the gene ACE2 and COVID-19.